Bristol-Myers Squibb Co. (NYSE:BMY)

Current assets exhibited volatility over the five-year period. Initially decreasing from 2021 to 2022, they subsequently increased in 2023 before declining again in 2024 and 2025. Adjusted current assets mirrored this pattern, demonstrating a similar trajectory throughout the observed timeframe.

Overall Trend

The figures indicate a general stabilization around the US$29-32 billion range, despite intermediate fluctuations. The initial decline from 2021 to 2022 was the most substantial change, representing a decrease of approximately US$6 billion in both current and adjusted assets. Subsequent changes were less pronounced.

Year-over-Year Changes

From 2021 to 2022, both current and adjusted assets decreased by approximately 18%. A recovery occurred between 2022 and 2023, with both figures increasing by roughly 17%. The period from 2023 to 2024 saw a decrease of approximately 5% for both measures. Finally, a slight decrease was observed from 2024 to 2025, with both values declining by approximately 1%.

Adjustments

The difference between current assets and adjusted current assets remains consistently small across all reported years, generally ranging between US$20 and US$50 million. This suggests that the adjustments made are relatively minor in comparison to the overall value of current assets. The consistent application of these adjustments indicates a standardized accounting practice.

The observed fluctuations in current assets warrant further investigation to determine the underlying drivers. Potential factors could include changes in inventory levels, accounts receivable, or short-term investments. The stability of the adjustments suggests they are not directly correlated with the broader fluctuations in current asset values.

Total assets exhibited a consistent decline over the five-year period from 2021 to 2025. Simultaneously, adjusted total assets also demonstrated a downward trend, though the magnitude of the decrease differed. A comparison of the two figures reveals a consistent difference, suggesting systematic adjustments are being made to the reported asset value.

Overall Trend

Reported total assets decreased from US$109,314 million in 2021 to US$90,038 million in 2025, representing a cumulative reduction of approximately 17.7%. The rate of decline appears to be accelerating, with larger decreases observed in the later years of the period. Adjusted total assets followed a similar pattern, decreasing from US$107,896 million in 2021 to US$84,718 million in 2025, a reduction of roughly 21.5%.

Magnitude of Adjustments

The difference between total assets and adjusted total assets ranged from approximately US$1,418 million in 2021 to US$5,320 million in 2025. This widening gap indicates that the adjustments made to total assets are becoming increasingly substantial over time. The adjustments consistently represent a reduction in the reported asset value.

Year-over-Year Changes

The largest year-over-year decrease in total assets occurred between 2021 and 2022, with a reduction of US$12,494 million. The decrease between 2024 and 2025 was US$2,570 million, representing a slower rate of decline compared to the earlier period, but still contributing to the overall downward trend. Adjusted total assets experienced its largest decrease between 2022 and 2023, with a reduction of US$2,745 million.

The consistent and increasing adjustments to total assets warrant further investigation to understand the nature of these adjustments and their potential impact on the company’s financial position. The accelerating rate of decline in both reported and adjusted total assets suggests a potential shift in the company’s asset base or accounting practices.

Total liabilities exhibited volatility over the five-year period. Initially decreasing, they subsequently increased before concluding with a slight decline. Adjusted total liabilities mirrored this pattern, though with differing magnitudes of change.

Overall Trend

From 2021 to 2022, both total liabilities and adjusted total liabilities decreased. Total liabilities fell from US$73,308 million to US$65,702 million, while adjusted total liabilities decreased from US$68,706 million to US$63,489 million. This represents a reduction of approximately 10.3% and 7.7%, respectively. A period of relative stability followed between 2022 and 2023, with minimal change in either metric.

Increase in 2024

A significant increase occurred in 2024. Total liabilities rose to US$76,215 million, and adjusted total liabilities reached US$75,549 million. This represents an increase of approximately 15.9% and 18.7% from the prior year. This is the largest single-year increase observed in the period.

Subsequent Adjustment

In 2025, both metrics experienced a moderate decrease. Total liabilities declined to US$71,533 million, and adjusted total liabilities decreased to US$70,996 million. This represents a decrease of approximately 6.2% and 6.0% from 2024. The 2025 values remain above those recorded in 2022 and 2023, indicating a sustained, albeit reduced, level of liabilities.

Relationship Between Metrics

The difference between total liabilities and adjusted total liabilities remained relatively consistent throughout the period, generally ranging between US$4,600 million and US$5,600 million. This suggests that the adjustments applied are systematic and do not represent drastic revisions to the underlying liability structure. The adjustments consistently represent approximately 6-8% of total liabilities.

The fluctuations in both total and adjusted liabilities warrant further investigation to understand the underlying drivers, particularly the substantial increase observed in 2024. The consistent difference between the two metrics suggests a recurring adjustment process that should be examined for its nature and impact.

Total shareholders’ equity exhibited a declining trend from 2021 to 2024, followed by a modest increase in 2025. Simultaneously, adjusted total equity mirrored this pattern, though the magnitude of the decline and subsequent increase differed. A comparison of the two equity measures reveals consistent adjustments impacting the overall equity position.

Overall Equity Trend

Total shareholders’ equity decreased from US$35,946 million in 2021 to US$16,335 million in 2024, representing a substantial reduction. A slight recovery was observed in 2025, with equity rising to US$18,473 million. Adjusted total equity followed a similar trajectory, declining from US$39,190 million in 2021 to US$12,863 million in 2024, and increasing to US$13,724 million in 2025.

Magnitude of Adjustments

The difference between total shareholders’ equity and adjusted total equity was approximately US$3,244 million in 2021. This difference widened to US$5,948 million in 2022, then narrowed to US$5,164 million in 2023. The largest discrepancy occurred in 2024, reaching US$3,472 million, before decreasing to US$2,749 million in 2025. This indicates that the adjustments made to equity have varied in magnitude over the period.

Rate of Decline

The most significant decline in total shareholders’ equity occurred between 2022 and 2023, with a decrease of US$1,631 million. The largest decrease in adjusted total equity also occurred between 2022 and 2023, with a decrease of US$1,943 million. The period between 2023 and 2024 saw further substantial declines in both measures, though at a slower rate than the prior year.

2025 Reversal

The increase in both total and adjusted equity in 2025, while modest, represents a potential shift in trend. However, both values remain significantly below their 2021 levels. Further investigation would be required to determine the sustainability of this increase.

The consistent presence of adjustments to equity suggests the application of accounting treatments impacting the reported equity position. The fluctuations in the magnitude of these adjustments warrant further scrutiny to understand the underlying causes and their implications for the company’s financial health.

Over the five-year period ending December 31, 2025, both reported and adjusted financial figures demonstrate notable shifts in the company’s capital structure. Total reported debt decreased from 2021 to 2022, remained relatively stable through 2023, and then increased significantly in 2024 before declining slightly in 2025. Shareholders’ equity consistently decreased from 2021 to 2024, with a modest increase observed in 2025. Consequently, total reported capital followed a similar pattern to debt, decreasing initially and then increasing in 2024 before a slight decrease in 2025.

Adjusted figures mirror these trends, though with differing magnitudes. Adjusted total debt exhibited a similar pattern to reported debt, while adjusted total equity experienced a more pronounced decline from 2021 to 2024, followed by a small increase in 2025. Adjusted total capital also followed a comparable trajectory to the reported total capital.

Debt Trends

Reported total debt decreased by approximately 11.7% from 2021 to 2022, followed by a 0.6% increase from 2022 to 2023. A substantial increase of 24.8% occurred between 2023 and 2024, and a subsequent decrease of 3.1% was observed between 2024 and 2025. Adjusted total debt showed a similar pattern, with a decrease of 8.7% from 2021 to 2022, a 2.1% increase from 2022 to 2023, a 23.4% increase from 2023 to 2024, and a 2.9% decrease from 2024 to 2025. The adjusted debt figures are consistently higher than the reported debt figures throughout the period.

Equity Trends

Total BMS shareholders’ equity decreased by 13.6% from 2021 to 2022, then by 5.2% from 2022 to 2023, and a significant 62.1% decline from 2023 to 2024. A modest increase of 7.7% was seen from 2024 to 2025. Adjusted total equity mirrored this trend, with a 18.3% decrease from 2021 to 2022, a 3.7% decrease from 2022 to 2023, a 58.8% decrease from 2023 to 2024, and a 6.7% increase from 2024 to 2025. The adjusted equity figures are consistently higher than the reported equity figures throughout the period.

Capital Structure

Total reported capital decreased from 2021 to 2024, falling by 19.1% over that period, before a slight decrease of 1.9% in 2025. Adjusted total capital followed a similar pattern, decreasing by 17.8% from 2021 to 2024, and then decreasing by 1.6% in 2025. The difference between reported and adjusted total capital widened from US$4.3 million in 2021 to US$4.9 million in 2025.

The substantial decline in equity, particularly in 2024, coupled with the increase in debt during the same period, suggests a shift towards greater financial leverage. The modest recovery in equity in 2025 may indicate a stabilization, but further monitoring is warranted. The consistent difference between reported and adjusted figures suggests the presence of items impacting the capitalization that are being accounted for in the adjustments.

Net earnings attributable to Bristol-Myers Squibb exhibited volatility over the five-year period. Initially, a decrease from US$6,994 million in 2021 to US$6,327 million in 2022 was observed, followed by a recovery to US$8,025 million in 2023. However, a substantial loss of US$8,948 million was reported in 2024, before rebounding to a profit of US$7,054 million in 2025. Adjusted net earnings mirrored this trend, though with differing magnitudes.

Trend in Net Earnings

The fluctuation in net earnings suggests potential underlying business factors impacting profitability. The significant loss in 2024 warrants further investigation to determine the contributing causes, such as potential impairments, restructuring charges, or unfavorable market conditions. The subsequent recovery in 2025 indicates a possible reversal of these factors or the impact of new initiatives.

Trend in Adjusted Net Earnings

Adjusted net earnings demonstrate a more pronounced decline from 2021 to 2022, falling from US$6,148 million to US$3,541 million. While showing some improvement in 2023 to US$4,629 million, the adjusted figure experienced a larger loss in 2024, reaching US$10,583 million, compared to the reported net loss. The recovery in 2025 to US$5,836 million, while positive, remains below the 2021 level. This suggests that adjustments are having a significant impact on the overall earnings picture, particularly in 2024.

Relationship Between Reported and Adjusted Earnings

The difference between net earnings and adjusted net earnings indicates the presence of items that management deems non-recurring or unusual. The magnitude of these adjustments varied across the period. In 2024, the adjusted net loss significantly exceeded the reported net loss, implying substantial one-time charges or accounting adjustments were made. This divergence highlights the importance of understanding the nature of these adjustments to assess the company’s underlying operational performance.

Overall, the financial performance appears sensitive to adjustments. A detailed review of the components of these adjustments is crucial for a comprehensive understanding of the company’s financial health and future prospects.